Clinical outcomes of FILI(Femtoseconlaser Intrastromal Lenticular Implantation)with accelerated cross linkage for low to moderate degrees of keratoconus - FILI KC

Research Foundation Nethradhama Eye Hospital0 个研究点目标入组 30 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•ï??Mild to moderate degrees of keratoconus
•ï??Documented evidence of progressive keratoconus
•ï?? Best Spectacle Corrected Visual Acuity (BSCVA) > 6/24
•ï??Age ( 21- 40 years )
•ï??Intolerance to RGP /Rose K/ Scleral lenses
•ï??Central cone on topography
•ï??Soft contact lens discontinued for minimum 1 week and Rigid Gas Permeable contact lens discontinued for minimum 3 weeks
•ï??Ability to understand and willingness to sign informed consent
•ï??Willingness to participate in follow up visits

•Age >40 years
•Advanced keratoconus with apical scarring
•Steep K values <58 D
•Thinnest pachymetery <400 Âµm
•Minimum midperipheral pachymetery of 350Âµm or more
•Endothelial Cell count > 1500 cells/mmÂ²
•Eccentric cone distribution on topography
•Active atopic keratoconjunctivitis / Vernal catarrh
•Evidence of ocular diseases like severe meibomian gland diseases, herpetic keratitis, uvietis, glaucoma.
•Corneal ectasia due to previous laser ablative surgery(LASIK/ PRK)
•H/o Riboflavin allergy
•Dry eye status-Schirmerâ??s I value less than 10 mm
•Long term ocular medication like Î² blockers.
•Concurrent use of systemic medication likely to affect wound healing like corticosteroids or antimetabolites.
•H/o immunocompromised state /pregnancy / nursing mothers .
•Patients with unrealistic expectations.

发起方

Research Foundation Nethradhama Eye Hospital